T1	Participants 680 958	Eligibility included adults with an estimated life expectancy of between 1 month and 1 year, statin therapy for 3 months or more for primary or secondary prevention of cardiovascular disease, recent deterioration in functional status, and no recent active cardiovascular disease
T2	Participants 1087 1141	study was conducted from June 3, 2011, to May 2, 2013.
T3	Participants 1616 1653	A total of 381 patients were enrolled
T4	Participants 1753 1862	Mean (SD) age was 74.1 (11.6) years, 22.0% of the participants were cognitively impaired, and 48.8% had cance
